S-S2 BMT Tandem Luncheon Symposium: Multiple Myeloma Treatments for the Transplant-Eligible and Non-Transplant Eligible Patient

Track: BMT Tandem "Scientific" Meeting
Wednesday, February 13, 2013: 12:30 PM-1:30 PM
Ballroom A-H (Salt Palace Convention Center)
Chair:
Sagar Lonial, MD
Summary:

Supported by independent educational grants from Celgene Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceuticals.

Frontline Treatment of Patients with Multiple Myeloma Who Are Transplant Ineligible
Sagar Lonial, MD, Emory University Winship Cancer Institute

Translating Clinical Findings into Practice: Primary and Maintenance Therapy for Transplant Candidates
Philip L. McCarthy, MD, Roswell Park Cancer Institute

Autologous Hemopoietic Stem Cell Transplantation Followed by Allogeneic or Autologous Hemopoietic Stem Cell Transplantation
Amrita Y. Krishnan, MD, City of Hope Medical Center

See more of: BMT Tandem "Scientific" Meeting
<< Previous Session | Next Session >>